Same day ART initiation versus clinic-based pre-ART assessment and counselling for individuals newly tested HIV-positive during community-based HIV testing in rural Lesotho - A randomized controlled trial (CASCADE trial)

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Labhardt, Niklaus Daniel ^a,b   Ringera, Isaac ^c   Lejone, Thabo Ishmael ^c   Masethothi, Phofu ^c   Thaanyane, T'Sepang ^c   Kamele, Mashaete ^c   Gupta, Ravi Shankar ^d   Thin, Kyaw ^d   Cerutti, Bernard ^e   Klimkait, Thomas ^b   Fritz, Christiane ^c   Glass, Tracy Renée ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c SolidarMed   (Lesotho)

^d Lesotho Ministry of Health National Tuberculosis Program   (Lesotho)

^e UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Africa; Antiretroviral therapy; Care cascade; HIV; Lesotho; Linkage to care; Randomized controlled trial; Retention in care; Viral suppression

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; COMMUNITY CARE; CONTROLLED STUDY; COUNSELING; FEMALE; HIV SEROPOSITIVITY; HOME CARE; HUMAN; LESOTHO; MALE; MASS SCREENING; METHODOLOGY; PATIENT ATTITUDE; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL; RURAL HEALTH CARE; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ANTI-RETROVIRAL AGENTS; COMMUNITY HEALTH SERVICES; COUNSELING; FEMALE; HIV SEROPOSITIVITY; HOME CARE SERVICES; HUMANS; LESOTHO; MALE; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; REFERRAL AND CONSULTATION; RESEARCH DESIGN; RURAL HEALTH SERVICES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84966405113     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-2972-6     Document Type: Article

References (41)

1. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. UNAIDS/JC2684 (accessed 30th October 2014 at www.unaids.org) 2014.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
3. Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, Gallant JE, Kumwenda J, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim J, Badal-Faesen S, Akelo V, Hosseinipour MC, Santos BR, Godbole SV, Pilotto JH, Grinsztejn B, Panchia R, Mayer KH, Chen YQ, Cohen MS, Eshleman SH: HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. J Acquir Immune Defic Syndr; 2016. [Epub ahead of print].
4. Jones A, Cremin I, Abdullah F, Idoko J, Cherutich P, Kilonzo N, Rees H, Hallett T, O'Reilly K, Koechlin F, Schwartlander B, de Zalduondo B, Kim S, Jay J, Huh J, Piot P, Dybul M. Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet 2014.384:272-79.
5. TEMPRANO ANRS 12136 Study Group. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med 2015;373:808-822.
6. INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373:795-807.
7. World Health Organization: GUIDELINE ON WHEN TO START ANTIRETROVIRAL THERAPY AND ON PRE-EXPOSURE PROPHYLAXIS FOR HIV. accessed 2 October 2015 at: http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/2015, ISBN 978 92 4 150956 5.
8. Hull M, Lange J, Montaner JSG. Treatment as prevention - where next? Curr HIV/AIDS Rep. 2014;11:496-504.
9. Delva W, Abdool Karim Q. The HIV epidemic in Southern Africa - Is an AIDS-free generation possible? Curr HIV/AIDS Rep. 2014;11:99-108.
10. MacCarthy S, Hoffmann M, Ferguson L, Nunn A, Irvin R, Bangsberg D, Gruskin S, Dourado I. The HIV care cascade: models, measures and moving forward. J Int AIDS Soc. 2015;18:19395.
11. Yehia BR, Stephens-Shields AJ, Fleishman JA, Berry SA, Agwu AL, Metlay JP, Moore RD, Christopher Mathews W, Nijhawan A, Rutstein R, Gaur AH, Gebo KA, HIV Research Network. The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppression. PLoS One. 2015;10:e0129376.
12. Piñeirúa A, Sierra-Madero J, Cahn P, Guevara Palmero RN, Martínez Buitrago E, Young B, Del Rio C. The HIV care continuum in Latin America: challenges and opportunities. Lancet Infect Dis. 2015;15:833-9.
13. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15:17383.
14. Mills EJ, Nachega JB, Ford N. Can we stop AIDS with antiretroviral-based treatment as prevention? Glob Health Sci Pract. 2013;1:29-34.
15. Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M, UNAIDS-Lancet Commission. Defeating AIDS-advancing global health. Lancet 2015.
16. Nachega JB, Uthman OA, del Rio C, Mugavero MJ, Rees H, Mills EJ. Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation. Clin Infect Dis. 2014;59 Suppl 1:S21-7.
17. Naik R, Doherty T, Jackson D, Tabana H, Swanevelder S, Thea DM, Feeley FG, Fox MP. Linkage to care following a home-based HIV counselling and testing intervention in rural South Africa. J Int AIDS Soc. 2015;18:19843.
18. Parker LA, Jobanputra K, Rusike L, Mazibuko S, Okello V, Kerschberger B, Jouquet G, Cyr J, Teck R. Feasibility and effectiveness of two community based HIV testing models in rural Swaziland. Trop Med Int Health. 2015;20:893-902.
19. Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, Gay C, Sanne I, Fox MP. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013;62:e39-46.
20. Gerdts SE, Wagenaar BH, Micek MA, Farquhar C, Kariaganis M, Amos J, Gimbel S, Pfeiffer J, Gloyd S, Sherr K. Linkage to HIV Care and Antiretroviral Therapy by HIV Testing Service Type in Central Mozambique: A Retrospective Cohort Study. J Acquir Immune Defic Syndr 2013;66:e37-e44.
21. Bassett I, Regan S, Luthuli P, Mbonambi H, Bearnot B, Pendleton A, Robine M, Mukuvisi D, Thulare H, Walensky R, Freedberg K, Losina E, Mhlongo B: Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa. HIV Med. 2013;15:367-372.
22. Labhardt ND, Motlomelo M, Cerutti B, Pfeiffer K, Kamele M, Hobbins MA, Ehmer J. Home-Based Versus Mobile Clinic HIV Testing and Counseling in Rural Lesotho: A Cluster-Randomized Trial. PLoS Med. 2014;11:e1001768.
23. Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N. Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review. J Int AIDS Soc. 2014;17:18809.
24. Kohler PK, Chung MH, McGrath CJ, Benki-Nugent SF, Thiga JW, John-Stewart GC. Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya. AIDS. 2011;25:1657-61.
25. Cantrell RA, Sinkala M, Megazinni K, Lawson-Marriott S, Washington S, Chi BH, Tambatamba-Chapula B, Levy J, Stringer EM, Mulenga L, Stringer JSA. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49:190-5.
26. Muhamadi L, Tumwesigye NM, Kadobera D, Marrone G, Wabwire-Mangen F, Pariyo G, Peterson S, Ekström AM. A single-blind randomized controlled trial to evaluate the effect of extended counseling on uptake of pre-antiretroviral care in Eastern Uganda. Trials. 2011;12:184.
27. Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, Niyigena P, Walker KDC, Epino H, Binagwaho A, Mukherjee J, Farmer PE, Rich ML. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. Clin Infect Dis. 2013;56:1319-26.
28. Hatcher AM, Turan JM, Leslie HH, Kanya LW, Kwena Z, Johnson MO, Shade SB, Bukusi EA, Doyen A, Cohen CR. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav. 2012;16:1295-307.
29. Okeke NL, Ostermann J, Thielman NM. Enhancing linkage and retention in HIV care: a review of interventions for highly resourced and resource-poor settings. Curr HIV/AIDS Rep. 2014;11:376-92.
30. Govindasamy D, Meghij J, Kebede Negussi E, Clare Baggaley R, Ford N, Kranzer K. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings - a systematic review. J Int AIDS Soc. 2014;17:19032.
31. Posse M, Baltussen R. Costs of providing food assistance to HIV/AIDS patients in Sofala province, Mozambique: a retrospective analysis. Cost Eff Resour Alloc. 2013;11:20.
32. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26:2059-67.
33. Williams BG, Gouws E, Somse P, Mmelesi M, Lwamba C, Chikoko T, Fazito E, Turay M, Kiwango E, Chikukwa P, Damisoni H, Gboun M. Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the Elimination Targets. Curr HIV/AIDS Rep. 2015;12:196-206.
34. UNAIDS. Developing subnational estimates of HIV prevalence and the number of people living with HIV from survey data. JC2665E (accessed 2O ctober 2015 at: http://www.unaids.org/sites/default/files/media-asset/2014-subnationalestimatessurvey-Lesotho-en.pdf) 2014,.
35. Ministry of Health and Social Welfare Lesotho. National Guidelines For HIV Testing And Counselling, National Guidelines For HIV Testing And Counselling. 2009.
36. Ministry of Health of Lesotho. National guidelines on the use of antiretroviral therapy for HIV prevention and treatment, National guidelines on the use of antiretroviral therapy for HIV prevention and treatment. 2013.
37. World Health Organization: Consolidated Guidelines on the Use of antiretroviral Drugs for treating and preventing HIV Infection. available at: www.who.int, 2013. Accessed 15 May 2015.
38. Smith JA, Sharma M, Levin C, Baeten JM, van Rooyen H, Celum C, Hallett TB, Barnabas RV. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV. 2015;2:e159-68.
39. Genberg BL, Naanyu V, Wachira J, Hogan JW, Sang E, Nyambura M, Odawa M, Duefield C, Ndege S, Braitstein P. Linkage to and engagement in HIV care in western Kenya: An observational study using population-based estimates from home-based counseling and testing. Lancet HIV. 2015;2:e20-6.
40. Ferrand R, Ford N, Kranzer K. Maximising the benefits of home-based HIV testing. Lancet HIV. 2015;2:e4-5.
41. Rosen S, Maskew M, Fox MP, Nyoni C, Constance M, Given G, Ian I, Julia RK, Lawrence L. Rapid ART Initiation Reduces Loss Between HIV Testing and Treatment: The RapIT Trial. Abstract presentation CROI conference Feb 22-25, 2016; Abstract Number 1091 2016, (accessed 3 March 2016 at: http://www.croiconference.org/sessions/rapid-art-initiation-reduces-loss-between-hiv-testing-and-treatment-rapit-trial).